Type A aortic dissection in a patient on dabigatran: Hemostasis post circulatory arrest

Annals of Thoracic Surgery

Volumn 98, Issue 6, 2014, Pages 2215-2216

  Ashikhmina, Elena ^a   Tomasello, Nicole ^a   Connors, Jean Marie ^a   Jahanyar, Jama ^a   Davidson, Michael ^a   Mizuguchi, K Annette ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AMINOCAPROIC ACID; DABIGATRAN; FRESH FROZEN PLASMA; HEPARIN; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE;

AGED; AORTA CLAMPING; AORTA DISSECTION; ARTICLE; ASCENDING AORTA SURGERY; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; DIAPHORESIS; DRUG BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEART ARREST; HEMODIALYSIS; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; OBESITY; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PROTHROMBIN TIME; RENAL REPLACEMENT THERAPY; THORAX PAIN; THROMBOCYTE TRANSFUSION; TYPE A AORTIC DISSECTION; ANALOGS AND DERIVATIVES; ANEURYSM, DISSECTING; AORTIC ANEURYSM, THORACIC; CHEMICALLY INDUCED; PROCEDURES; VASCULAR SURGERY;

AGED; ANEURYSM, DISSECTING; ANTITHROMBINS; AORTIC ANEURYSM, THORACIC; BENZIMIDAZOLES; BETA-ALANINE; HEMOSTATIC TECHNIQUES; HUMANS; MALE; POSTOPERATIVE HEMORRHAGE; VASCULAR SURGICAL PROCEDURES;

EID: 84919428721     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2014.01.077     Document Type: Article

References (8)

1. Prescribing information. Dabigatran etexilate (Pradaxa) October 2010 Boehringer Ingelheim Pharmaceuticals, Inc Ridgefield, CT Available at http://www.pradaxa.com. Accessed December 4, 2013.
2. J.G. Augoustides Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor J Cardiothorac Vasc Anesth 25 2011 1208 1212
3. J. Stangier, K. Rathgen, H. Stähle, and D. Mazur Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study Clinical pharmacokinet 49 2010 259 268
4. M.R. Wanek, E.T. Horn, S. Elapavaluru, S.C. Baroody, and G. Sokos Safe use of hemodialysis for dabigatran removal before cardiac surgery Ann Pharmacother 46 2012 e21
5. T.E. Warkentin, P. Margetts, S.J. Connolly, A. Lamy, C. Ricci, and J.W. Eikelboom Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding Blood 119 2012 2172 2174
6. E.S. Eerenberg, P.W. Kamphuisen, M.K. Sijpkens, J.C. Meijers, H.R. Buller, and M. Levi Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects Circulation 124 2011 1573 1579
7. T.L. Khoo, C. Weatherburn, G. Kershaw, C.J. Reddel, J. Curnow, and S. Dunkley The use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran Int J Lab Hematol 35 2013 222 224
8. J. Van Ryn, J. Stangier, and S. Haertter Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127